Dr. Kwabena Ayesu, MD

Dr. Ayesu practices at Arnold Palmer Hospital for Children in Orlando, Florida.

Dr. Ayesu's NPI, 1225019284, was assigned on November 8, 2005. Dr. Ayesu graduated from Karlovy University FOM in 1982. Dr. Ayesu holds Florida license ME87178.

Dr. Ayesu's primary practice is Arnold Palmer Hospital for Children, at 92 W Miller St, Orlando, FL 32806 in Orange County. The practice phone is (407) 650-5028.

Dr. Ayesu's primary practice is Arnold Palmer Hospital for Children in Orlando, Florida. Dr. Ayesu is also affiliated with Orlando Regional Medical Center. The medical group on file is Orlando Health Medical Group. Dmand AI also links Dr. Ayesu to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ayesu practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ayesu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ayesu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ayesu's licenses on file in 4 states: Florida, Virginia, District of Columbia and Maryland.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, atherosclerosis, bile duct problems, cardiac arrhythmia, chest pain and circulation problems among the conditions Dr. Ayesu treats.

CMS data shows 726 Medicare services from Dr. Ayesu across 6 procedure codes in 2024, for 191 Medicare patients. Medicare paid $54,347 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 191 Medicare patients who saw Dr. Ayesu in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ayesu's median patient age at 72, with 55% women.

In 2024, Dr. Ayesu wrote 632 Medicare Part D claims for 240 patients. 84% of them were for generic drugs. CMS names the drug for 300 of them, across 19 drugs with 11 or more claims each, at $17,519 in total drug cost. In 2023, CMS named 203 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Ayesu for performance year 2024, reported as part of a group. Dr. Ayesu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Ayesu, published from 2011 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Community-Acquired Infections, Duodenal Ulcer and Gastric Acid. Dr. Ayesu has published most often in Am J Case Rep. Dr. Ayesu's most frequent co-authors are Mario Madruga, MD, Stephen Carlan, MD and Rodrigo Silva Cavallazzi, MD.

Dmand AI links Dr. Ayesu to 4 clinical trials. Conditions studied include Crohn Disease, Dermatomyositis and Lupus Erythematosus, Systemic. Open Payments lists research payments to Dr. Ayesu that name 4 trials.

CMS Open Payments shows 12 general payments to Dr. Ayesu from 3 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 77% of the total. Argenx US, Inc. paid the most, $1,544. It also lists 18 research payments totaling $264,195 from 2019 to 2024, naming 4 clinical trials.

Dr. Ayesu graduated from Karlovy University FOM in 1982. Dr. Ayesu is a member of ACP and SHM.

Dr. Ayesu is in network with 8 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicaid plans come from the most carriers, 3. Check the plan with the practice before a visit.